These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 29198920)
1. Impact of post-dilatation on longitudinal stent elongation: An in vitro study. Sumi T; Ishii H; Tanaka A; Suzuki S; Kojima H; Iwakawa N; Aoki T; Hirayama K; Mitsuda T; Harada K; Negishi Y; Ota T; Kada K; Murohara T J Cardiol; 2018 May; 71(5):464-470. PubMed ID: 29198920 [TBL] [Abstract][Full Text] [Related]
2. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months). Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909 [TBL] [Abstract][Full Text] [Related]
4. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial. Jensen LO; Thayssen P; Maeng M; Ravkilde J; Krusell LR; Raungaard B; Junker A; Terkelsen CJ; Veien KT; Villadsen AB; Kaltoft A; Tilsted HH; Hansen KN; Aaroe J; Kristensen SD; Hansen HS; Jensen SE; Madsen M; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412869 [TBL] [Abstract][Full Text] [Related]
5. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Smits PC; Hofma S; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; Vuillomenet A; Serra A; Nouche RT; den Heijer P; van der Ent M Lancet; 2013 Feb; 381(9867):651-60. PubMed ID: 23374650 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of post-dilatation on longitudinal stent deformation and postprocedural stent malapposition in the left main artery by optical coherence tomography (OCT): an in vitro study. He Q; Fan Y; Xu Z; Zhang J BMC Med Imaging; 2024 Mar; 24(1):53. PubMed ID: 38429683 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236 [TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial. Jensen LO; Thayssen P; Maeng M; Ravkilde J; Hansen HS; Jensen SE; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH Am Heart J; 2015 Aug; 170(2):210-5. PubMed ID: 26299216 [TBL] [Abstract][Full Text] [Related]
9. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
10. Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort. Rhee TM; Park KW; Lee JM; Lee MS; Jeon KH; Kang HJ; Koo BK; Rhew JY; Cha KS; Bae JH; Han KR; Park SH; Park WJ; Rha SW; Oh SK; Kwon HM; Seung KB; Ahn T; Kim SH; Kim HS Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146671 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Parsa E; Saroukhani S; Majlessi F; Poorhosseini H; Lofti-Tokaldany M; Jalali A; Salarifar M; Nematipour E; Alidoosti M; Aghajani H; Amirzadegan A; Kassaian SE Tex Heart Inst J; 2016 Apr; 43(2):126-30. PubMed ID: 27127426 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Kadota K; Muramatsu T; Iwabuchi M; Saito S; Hayashi Y; Ikari Y; Nanto S; Fujii K; Inoue N; Namiki A; Kimura T; Mitsudo K Catheter Cardiovasc Interv; 2012 Nov; 80(5):789-96. PubMed ID: 21805606 [TBL] [Abstract][Full Text] [Related]